Merck's Keytruda is the standard of care for NSCLC. Ivonescimab, however, shows clinically meaningful benefit over Keytruda in a phase III study in...

Merck's Keytruda is the standard of care for NSCLC. Ivonescimab, however, shows clinically meaningful benefit over Keytruda in a phase III study in...

MRK's Keytruda gets approval in combination with Astellas and Pfizer's Padcev for treating first-line advanced urothelial carcinoma.

MRK's Keytruda gets approval in combination with Astellas and Pfizer's Padcev for treating first-line advanced urothelial carcinoma.

Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.

  The Irish Data Protection Commission (DPC) recently took a decisive step against the tech giant X, resulting in the immediate suspension of its use...

  The Irish Data Protection Commission (DPC) recently took a decisive step against the tech giant X, resulting in the immediate suspension of its use...

FDA approves J&J's Tremfya for ulcerative colitis. NVO's oral obesity pill, amycretin, shows faster weight loss than weekly injection, Wegovy.

TERN has outperformed the industry in the past three months on encouraging pipeline progress of its candidates. Positive data on obesity candidates...

Global ERP provider Strategic has expanded its engagement with TLE.market to help Strategic accelerate sales pipeline growth while maintaining high...